{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:25:07Z","timestamp":1792013107962,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014804","name":"Neurofibromatosis Therapeutic Acceleration Program","doi-asserted-by":"publisher","award":["230115"],"award-info":[{"award-number":["230115"]}],"id":[{"id":"10.13039\/100014804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jid.2024.01.028","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T21:15:33Z","timestamp":1708118133000},"page":"1754-1761.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose\/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3528-9804","authenticated-orcid":false,"given":"Laura","family":"Fertitta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2655-6481","authenticated-orcid":false,"given":"Arnaud","family":"Jannic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-1885","authenticated-orcid":false,"given":"Ouidad","family":"Zehou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4985-6785","authenticated-orcid":false,"given":"Christina","family":"Bergqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8821-2806","authenticated-orcid":false,"given":"Salah","family":"Ferkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4141-5613","authenticated-orcid":false,"given":"Sabine","family":"Moryousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3710-1734","authenticated-orcid":false,"given":"Lionel","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6896-6149","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Mul\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-9474","authenticated-orcid":false,"given":"Alain","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4958-7458","authenticated-orcid":false,"given":"Blanche","family":"Bapst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-4589","authenticated-orcid":false,"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-7422","authenticated-orcid":false,"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-4058","authenticated-orcid":false,"given":"Emmanuel","family":"Itti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8194-457X","authenticated-orcid":false,"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2024.01.028_bib1","first-page":"e1076","article-title":"Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1 [published correction appears in Neurology 2020;94:504]","volume":"93","author":"Ahlawat","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2024.01.028_bib2","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1212\/WNL.0000000000002929","article-title":"Current whole-body MRI applications in the neurofibromatoses. NF1, NF2, and schwannomatosis","volume":"87","author":"Ahlawat","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2024.01.028_bib3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2967\/jnumed.109.074229","article-title":"Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET","volume":"51","author":"Benz","year":"2010","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jid.2024.01.028_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(04)15433-0","article-title":"Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries","volume":"363","author":"Berrington de Gonz\u00e1lez","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2024.01.028_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1148\/radiol.13121838","article-title":"Simultaneously acquired MR\/PET images compared with sequential MR\/PET and PET\/CT: alignment quality","volume":"268","author":"Brendle","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jid.2024.01.028_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101818","article-title":"ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1","volume":"56","author":"Carton","year":"2023","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.jid.2024.01.028_bib7","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3","article-title":"Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group","volume":"91","author":"Coindre","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.jid.2024.01.028_bib8","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1097\/RLU.0b013e318266ce84","article-title":"Comparative effectiveness of 18F-FDG PET\/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1","volume":"38","author":"Derlin","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jid.2024.01.028_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1172-6-18","article-title":"Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980\u20132006 in France","volume":"6","author":"Duong","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2024.01.028_bib10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00259-017-3736-y","article-title":"Integrated 18F-FDG PET\/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial","volume":"44","author":"Erfanian","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jid.2024.01.028_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jid.2024.01.028_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jid.2024.01.028_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2045-3329-2-17","article-title":"Malignant peripheral nerve sheath tumours in inherited disease","volume":"2","author":"Evans","year":"2012","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.jid.2024.01.028_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/annonc\/mdm450","article-title":"[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study","volume":"19","author":"Ferner","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jid.2024.01.028_bib15","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2024.01.028_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp.68.3.353","article-title":"Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1","volume":"68","author":"Ferner","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jid.2024.01.028_bib17","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/neuonc\/noac146","article-title":"Management of neurofibromatosis type 1-associated plexiform neurofibromas","volume":"24","author":"Fisher","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jid.2024.01.028_bib18","series-title":"Neurofibromatosis: phenotype, natural history, and pathogenesis","year":"1999"},{"key":"10.1016\/j.jid.2024.01.028_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0344-0338(11)80700-4","article-title":"The pathologist and the residual tumor (R) classification","volume":"190","author":"Hermanek","year":"1994","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jid.2024.01.028_bib20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jmg.26.11.704","article-title":"A\u00a0genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity","volume":"26","author":"Huson","year":"1989","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jid.2024.01.028_bib21","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/gim.2017.215","article-title":"Prevalence of neurofibromatosis type 1 in the Finnish population","volume":"20","author":"Kallionp\u00e4\u00e4","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jid.2024.01.028_bib22","doi-asserted-by":"crossref","first-page":"A160","DOI":"10.1227\/01.NEU.0000337597.18599.D3","article-title":"Potential role of 18fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1","volume":"65","author":"Karabatsou","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jid.2024.01.028_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ajmg.a.30394","article-title":"Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients","volume":"132A","author":"Khosrotehrani","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jid.2024.01.028_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archderm.139.2.187","article-title":"Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients","volume":"139","author":"Khosrotehrani","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2024.01.028_bib25","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.wneu.2021.09.130","article-title":"Diffusion-weighted magnetic resonance imaging improves the accuracy of differentiation of benign from malignant peripheral nerve sheath tumors","volume":"157","author":"Koike","year":"2022","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jid.2024.01.028_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of neurofibromatosis 1 in German children at elementary school enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2024.01.028_bib27","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jid.2024.01.028_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/rpd\/ncz153","article-title":"Effective radiation dose of 18F-FDG PET\/CT: how much does diagnostic CT contribute?","volume":"187","author":"Li","year":"2019","journal-title":"Radiat Prot Dosimetry"},{"key":"10.1016\/j.jid.2024.01.028_bib29","first-page":"vdaa131","article-title":"Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival","volume":"2","author":"Lucas","year":"2020","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.jid.2024.01.028_bib30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00432-008-0523-y","article-title":"Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI","volume":"135","author":"Matsumine","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jid.2024.01.028_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jid.2024.01.028_bib32","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jid.2024.01.028_bib33","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/cas.14802","article-title":"Limitations and benefits of FDG-PET\/CT in NF1 patients with nerve sheath tumors: A cross-sectional\/longitudinal study","volume":"112","author":"Nishida","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jid.2024.01.028_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/wjnm.WJNM_71_17","article-title":"Comparison of hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging and positron emission tomography\/computed tomography for evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1","volume":"17","author":"Raad","year":"2018","journal-title":"World J Nucl Med"},{"key":"10.1016\/j.jid.2024.01.028_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-6-51","article-title":"At-risk phenotype of neurofibromatose-1 patients: a multicentre case-control study","volume":"6","author":"Sbidian","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2024.01.028_bib36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.clinimag.2015.05.014","article-title":"F-FDG PET\/MRI for therapy response assessment in sarcoma: comparison of PET and MR imaging results","volume":"39","author":"Schuler","year":"2015","journal-title":"Clin Imaging"},{"key":"10.1016\/j.jid.2024.01.028_bib37","article-title":"Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic review","volume":"2012","author":"Treglia","year":"2012","journal-title":"Radiol Res Pract"},{"key":"10.1016\/j.jid.2024.01.028_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1148\/radiol.2511080671","article-title":"The linear no-threshold relationship is inconsistent with radiation biologic and experimental data","volume":"251","author":"Tubiana","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.jid.2024.01.028_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1212\/01.wnl.0000168830.79997.13","article-title":"Association between benign and malignant peripheral nerve sheath tumors in NF1","volume":"65","author":"Tucker","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2024.01.028_bib40","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis Type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2024.01.028_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2015.12.015","article-title":"Management and prognosis of malignant peripheral nerve sheath tumors: the experience of the French Sarcoma Group (GSF-GETO)","volume":"56","author":"Valentin","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2024.01.028_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151809","article-title":"Metabolic tumour burden measured by 18F-FDG PET\/CT predicts malignant transformation in patients with neurofibromatosis Type-1","volume":"11","author":"Van Der Gucht","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2024.01.028_bib43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00259-008-1038-0","article-title":"[18F]FDG PET\/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1","volume":"36","author":"Warbey","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jid.2024.01.028_bib44","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2214\/AJR.09.2724","article-title":"MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas","volume":"194","author":"Wasa","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jid.2024.01.028_bib45","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/MNM.0000000000001237","article-title":"Role of 18F-FDG PET\/computed tomography in prognostication and management of malignant peripheral nerve sheath tumors","volume":"41","author":"Yadav","year":"2020","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jid.2024.01.028_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1750-1172-8-127","article-title":"Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review","volume":"8","author":"Zehou","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2024.01.028_bib47","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.mri.2015.10.027","article-title":"Synergistic role of simultaneous PET\/MRI-MRS in soft tissue sarcoma metabolism imaging","volume":"34","author":"Zhang","year":"2016","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.jid.2024.01.028_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40644-021-00438-y","article-title":"PET\/MR fusion texture analysis for the clinical outcome prediction in soft-tissue sarcoma","volume":"22","author":"Zhao","year":"2022","journal-title":"Cancer Imaging"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2400112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2400112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:55:31Z","timestamp":1754009731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X2400112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0022202X2400112X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2024.01.028","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose\/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2024.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}